ESIBIe003-A-10
General
Cell Line |
|
| hPSCreg name | ESIBIe003-A-10 |
| Cite as: | ESIBIe003-A-10 (RRID:CVCL_C0CN) |
| Cell line type | Human embryonic stem cell (hESC) |
| Similar lines |
ESIBIe003-A (HES-3, hES 3) ESIBIe003-A-4 (Envy) ESIBIe003-A-3 (hES3.3) ESIBIe003-A-1 (hES3.1) ESIBIe003-A-2 (hES3.2) ESIBIe003-A-11 (KIT+/- ESC) ESIBIe003-A-8 (KIT D816V ESC 1) ESIBIe003-A-12 (KIT-/- ESC) ESIBIe003-A-9 (KIT D816V ESC 2) ESIBIe003-A-7 (HES-3_44, IRF8-/- ES cell) |
| Last update | 28th September 2021 |
| User feedback | |
Provider |
|
| Generator | Murdoch Children's Research Institute (MCRI) |
| Derivation country | Australia |
External Databases |
|
| BioSamples | SAMEA9462434 |
| Cellosaurus | CVCL_C0CN |
| Wikidata | Q112929540 |
General Information |
|
| Publications | |
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
| Subclone of | |
Donor Information
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
Donor Relations |
|
| Other cell lines of this donor | |
External Databases (Donor) |
|
| BioSamples | SAMEA104620499 |
Ethics
Also have a look at the ethics information for the parental line
ESIBIe003-A
.
| Is there an MTA available for the cell line? | No |
| Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? | No |
hESC Derivation
|
The source cell information can be found in the parental cell line
ESIBIe003-A.
|
Culture Conditions
Characterisation
No characterisation data could be found for this subclone. Please open parental cell line ESIBIe003-A .Genotyping
Karyotyping (Cell Line) |
|
Other Genotyping (Cell Line) |
Genetic Modification
| Genetic modifications not related to a disease |
|
Login to share your feedback, experiences or results with the research community.